Doctor Thierry Olivry joins the ranks of Alergovet S.L.
Alergovet S.L., a laboratory specialized in veterinary allergy diagnosis and a company of the Nextmune group, announces the incorporation of Dr. Thierry Olivry to its ranks as a scientific and veterinary advisor in dermatology and allergy.
Dr. Olivry will be in charge of providing answers to the different recurrent questions of veterinarians, and at the same time, of dealing with all the members of the group with the most relevant and current information of the sector.
Megan Spencer, Director of Sales for Spectrum Veterinary, another member of the group, said:
“Allergies among dogs, cats and horses are common, problematic and undertreated. Allergy testing is a vital service that improves the lives of animals who suffer. This new relationship with Dr. Olivry will provide our clients a better outcome for both testing and treatment.”
Dr. Olivry is a 1984 graduate from the veterinary school of Toulouse (France).
After several years as one of the managing partners of the Frégis specialty clinic in Paris, he moved to the USA for a residency in dermatology and a PhD in comparative pathology at the University of California Davis. He is board-certified by both European and American Colleges of Veterinary Dermatology.
In the Fall of 2019, after 25 years as a tenured Faculty in veterinary dermatology at the North Carolina State University College of Veterinary Medicine, Dr. Olivry became a part-time Research Professor and joined Dr. Santosh Mishra’s laboratory to study the comparative neurobiology of itch.
From 2001 to 2004, he was the Chair of the International Task Force on Canine Atopic Dermatitis, and from 2008 to 2009, President of the European College of Veterinary Dermatology.
Dr. Olivry has received several awards, including the “ACVD Award for Excellence for Outstanding Contributions to Science and Education”, the “NCSU Clinician of the Year Award”, the “Pfizer Award for Research Excellence at NCSU”, the “World Small Animal Veterinary Association Hill’s Excellence in Veterinary Healthcare Award” and, in the Spring of 2020, the “ECVD Lifetime Career Award”.
He has been made an honorary member of both Latin American and European Societies of Veterinary Dermatology.
He has also authored more than 270 peer-reviewed articles, and he has been invited all over the world to lecture to veterinary and medical audiences. For more than two decades, he has been researching the mechanism and treatment of atopic dermatitis and itch in dogs. More recently, he also expanded into the characterization of food allergens in dogs and cats.
In recent statements, Dr. Olivry stated the following:
“I am excited to collaborate with Nextmune companies and bring my decades of experience as a clinician-scientist in immunodermatology to help develop the future of allergy testing and allergen immunotherapy”.
He is also “happy and honored” with Nextmune, having invested in his experience and great talent.